IFIRMASTA 150 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400926775575
  • CIP7 2677557
  • CIS 60488216
  • Registration number EU/1/08/480

What the source publishes

Holder
KRKA (SLOVENIE)
Active ingredients
IRBÉSARTAN, CHLORHYDRATE D'IRBÉSARTAN
Form
comprimé pelliculé
Package
plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2008-12-01
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400926775575
{
  "cis": "60488216",
  "cip7": "2677557",
  "form": "comprimé pelliculé",
  "name": "IFIRMASTA 150 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)",
  "cip13": "3400926775575",
  "holder": "KRKA (SLOVENIE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "KRKA (SLOVENIE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "4.77",
  "authorisedOn": "2008-12-01",
  "compositions": [
    {
      "name": "IRBÉSARTAN",
      "nature": "FT",
      "strength": "150 mg",
      "linkageNumber": "1",
      "substanceCode": "31416",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "CHLORHYDRATE D'IRBÉSARTAN",
      "nature": "SA",
      "strength": "172,21 mg",
      "linkageNumber": "1",
      "substanceCode": "54231",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "3.75",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "IFIRMASTA 150 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2013-02-21",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "IRBÉSARTAN",
    "CHLORHYDRATE D'IRBÉSARTAN"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/08/480",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400926775575"